Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
The Journal of Dermatological Treatment
|
May 7, 2015
Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacy
Teresa L Kauf, Jui-Chen Yang, Alexa B Kimball, et al.
Science Bulletin
|
January 31, 2023
Temperature dependent Raman and photoluminescence of vertical WS<sub>2</sub>/MoS<sub>2</sub> monolayer heterostructures
Zhijian Hu, Yanjun Bao, Ziwei Li, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
May 13, 2017
Self-Assembled Au/CdSe Nanocrystal Clusters for Plasmon-Mediated Photocatalytic Hydrogen Evolution
Run Shi, Yinhu Cao, Yanjun Bao, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 25, 2023
Cost-Effectiveness of Carbidopa-Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States
Rajesh Pahwa, Aristide Merola, Michael Soileau, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 8, 2014
Plasmonic hot electron induced structural phase transition in a MoS2 monolayer
Yimin Kang, Sina Najmaei, Zheng Liu, et al.
Advances in Therapy
|
May 21, 2021
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review
Angelo Antonini, Per Odin, Rajesh Pahwa, et al.
Journal of Medical Economics
|
July 5, 2016
Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn's disease in Argentina, Brazil, Colombia, and Mexico
Namita Tundia, Paulo Gustavo Kotze, Jorge Rojas Serrano, et al.
Journal of Parkinson'S Disease
|
January 2, 2021
Low Sustainment of High-Dose Oral Medication Regimens for Advanced Parkinson's Disease in Medicare Beneficiaries
Nabila Dahodwala, Jordan Jahnke, Amy R Pettit, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2020
Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population
Nabila Dahodwala, Pengxiang Li, Jordan Jahnke, et al.
American Journal of Clinical Dermatology
|
November 30, 2010
Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial
Alexa B Kimball, Arielle G Bensimon, Annie Guerin, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
The Journal of Dermatological Treatment
|
May 7, 2015
Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacy
Teresa L Kauf, Jui-Chen Yang, Alexa B Kimball, et al.
Science Bulletin
|
January 31, 2023
Temperature dependent Raman and photoluminescence of vertical WS<sub>2</sub>/MoS<sub>2</sub> monolayer heterostructures
Zhijian Hu, Yanjun Bao, Ziwei Li, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
May 13, 2017
Self-Assembled Au/CdSe Nanocrystal Clusters for Plasmon-Mediated Photocatalytic Hydrogen Evolution
Run Shi, Yinhu Cao, Yanjun Bao, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 25, 2023
Cost-Effectiveness of Carbidopa-Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States
Rajesh Pahwa, Aristide Merola, Michael Soileau, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 8, 2014
Plasmonic hot electron induced structural phase transition in a MoS2 monolayer
Yimin Kang, Sina Najmaei, Zheng Liu, et al.
Advances in Therapy
|
May 21, 2021
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review
Angelo Antonini, Per Odin, Rajesh Pahwa, et al.
Journal of Medical Economics
|
July 5, 2016
Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn's disease in Argentina, Brazil, Colombia, and Mexico
Namita Tundia, Paulo Gustavo Kotze, Jorge Rojas Serrano, et al.
Journal of Parkinson'S Disease
|
January 2, 2021
Low Sustainment of High-Dose Oral Medication Regimens for Advanced Parkinson's Disease in Medicare Beneficiaries
Nabila Dahodwala, Jordan Jahnke, Amy R Pettit, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2020
Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population
Nabila Dahodwala, Pengxiang Li, Jordan Jahnke, et al.
American Journal of Clinical Dermatology
|
November 30, 2010
Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial
Alexa B Kimball, Arielle G Bensimon, Annie Guerin, et al.
Page
of 8